GNH USA

Europe — EMA

Migraleve Yellow (Paracetamol, Codeine Phosphate)

GNH USA supplies Migraleve Yellow (Paracetamol & Codeine), an analgesic for migraine, tension‑type and other acute headaches.

Paracetamol, Codeine Phosphate

Request sourcing

1
Pack/s

What is Paracetamol, Codeine Phosphate?

Paracetamol, the active ingredient in Migraleve Yellow, is an analgesic presented as an oral tablet for systemic use. Together with codeine phosphate, it provides pain relief for migraine and other headache disorders in adult patients, helping to reduce the intensity and duration of acute attacks. It is formulated for rapid absorption to address sudden pain episodes.

GNH USA supplies Migraleve Yellow as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality compliance with EU standards and reliable logistics for global distribution.

What is Paracetamol, Codeine Phosphate used for?

Migraleve Yellow, containing paracetamol and codeine phosphate, is indicated for conditions involving acute headache and migraine pain. - Migraine: provides relief of moderate to severe migraine attacks, reducing pain and associated symptoms. - Tension‑type headache: alleviates pain intensity, helping patients resume normal activities. - Other acute headache: offers effective analgesia when alternative treatments are insufficient.

What are the side effects of Paracetamol, Codeine Phosphate?

Paracetamol and codeine phosphate may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea - Constipation - Drowsiness or sedation - Dizziness

Serious or Rare Side Effects: - Respiratory depression, especially at higher doses or in sensitive individuals - Severe allergic reactions such as anaphylaxis or skin rash - Liver toxicity from paracetamol overdose - Dependence or withdrawal symptoms with prolonged codeine use

What precautions apply to Paracetamol, Codeine Phosphate?

When using Migraleve Yellow, several precautions should be observed to minimize risk. - Pregnancy: consult a healthcare professional before use, as safety data are limited. - Alcohol consumption: avoid excessive alcohol, which can increase liver toxicity. - Liver disease: use with caution and consider dose adjustment in patients with hepatic impairment. - Kidney disease: monitor renal function, especially in patients with chronic kidney disease. - Opioid dependence: assess risk of dependence before prescribing codeine-containing products. - Store at ambient temperature: keep in the original packaging, protect from moisture and heat.

What does Paracetamol, Codeine Phosphate interact with?

Migraleve Yellow can interact with other medicines; awareness of major and moderate interactions helps ensure safe use.

Major Interactions (Avoid): - Other opioid analgesics: combined use may cause severe respiratory depression. - Alcohol or CNS depressants: increased sedation and respiratory risk. - MAO inhibitors: may enhance serotonergic effects leading to serotonin syndrome. - Additional paracetamol‑containing products: risk of cumulative hepatotoxicity.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs/SNRIs): possible increased risk of serotonin syndrome. - Antihistamines: may augment drowsiness and impair coordination.

Frequently asked questions

What is Migraleve Yellow used for?+
Migraleve Yellow is an over‑the‑counter oral tablet that combines paracetamol and codeine phosphate to treat moderate to severe migraine attacks, tension‑type headaches, and other acute headache episodes. It provides rapid analgesic relief, helping patients reduce pain intensity and resume normal activities.
How does paracetamol work in this product?+
Paracetamol works by inhibiting the central synthesis of prostaglandins, which are mediators that increase pain perception and fever. By reducing prostaglandin levels in the brain, it raises the pain threshold and contributes to the overall analgesic effect when combined with codeine.
What is the usual dose of Migraleve Yellow?+
The specific dose of Migraleve Yellow is determined by the prescribing healthcare professional based on the individual’s age, medical condition, and response to therapy. Patients should follow the prescriber’s instructions and not exceed the recommended amount indicated on the product label.
Is Migraleve Yellow safe during pregnancy or breastfeeding?+
Safety data for the combination of paracetamol and codeine during pregnancy or lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before using Migraleve Yellow to weigh potential benefits against possible risks.
How do I order Migraleve Yellow from GNH USA?+
To order Migraleve Yellow, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.
How does Migraleve Yellow compare with other migraine treatments?+
Migraleve Yellow combines a non‑opioid analgesic (paracetamol) with a weak opioid (codeine), offering a balance of pain relief and fewer gastrointestinal side effects compared with non‑steroidal anti‑inflammatory drugs (NSAIDs) such as ibuprofen. However, it carries opioid‑related risks, so clinicians consider patient history when choosing between options.
How should Migraleve Yellow be stored and handled?+
Store Migraleve Yellow at ambient temperature, preferably below 25 °C, in its original packaging. Keep the tablets away from moisture, direct sunlight and heat sources. Ensure the container is tightly closed to maintain product stability throughout its shelf life.
How is Migraleve Yellow administered?+
Migraleve Yellow is taken orally with a full glass of water. The tablet should be swallowed whole and not chewed or crushed. It is intended for adult use; children should not use this product unless specifically directed by a qualified healthcare professional.
What are the most serious risks associated with Migraleve Yellow?+
The most serious risks include respiratory depression, especially when combined with other central nervous system depressants, severe allergic reactions such as anaphylaxis, liver injury from excessive paracetamol intake, and the potential for dependence or withdrawal symptoms related to the codeine component.
Who should not use Migraleve Yellow?+
Migraleve Yellow should be avoided by individuals with known hypersensitivity to paracetamol, codeine, or any excipients in the tablet. It is also contraindicated in patients with severe respiratory depression, acute asthma attacks, or those taking monoamine oxidase inhibitors. Consultation with a healthcare professional is essential before use.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Paracetamol, Codeine Phosphate
Route
Oral Use
Manufacturer
Jntl Consumer Health I (Ireland) Limited
Origin
EU

Related products

Algocod

Algocod

Paracetamol, Codeine Phosphate

Laboratoires Smb S.A.
EU
Algocod

Algocod

Paracetamol, Codeine Phosphate

Laboratoires Smb S.A.
EU
Antidol

Antidol

Paracetamol, Codeine Phosphate

Sandoz Gmbh
EU
Co-Codamol

Co-Codamol

Paracetamol, Codeine Phosphate

Activase Pharmaceuticals Limited
EU